Minimum stable structure of the receptor for advanced glycation end product possesses multi ligand binding ability.

[1]  D. Beckett,et al.  A minimal peptide substrate in biotin holoenzyme synthetase‐catalyzed biotinylation , 2008, Protein science : a publication of the Protein Society.

[2]  Hiroshi Yamamoto,et al.  Effect of nitration on the physicochemical and kinetic features of wild-type and monotyrosine mutants of human respiratory cytochrome c. , 2008, Biochemistry.

[3]  R. Hoffmann,et al.  Structural Basis for Pattern Recognition by the Receptor for Advanced Glycation End Products (RAGE)* , 2008, Journal of Biological Chemistry.

[4]  Q. Xie,et al.  Expression and characterization of recombinant C-terminal biotinylated extracellular domain of human receptor for advanced glycation end products (hsRAGE) in Escherichia coli. , 2008, Journal of biochemistry.

[5]  C. Heizmann,et al.  The extracellular region of the receptor for advanced glycation end products is composed of two independent structural units. , 2007, Biochemistry.

[6]  I. Lednev,et al.  Hexameric Calgranulin C (S100A12) Binds to the Receptor for Advanced Glycated End Products (RAGE) Using Symmetric Hydrophobic Target-binding Patches* , 2006, Journal of Biological Chemistry.

[7]  C. Heizmann,et al.  Expression and purification of the soluble isoform of human receptor for advanced glycation end products (sRAGE) from Pichia pastoris. , 2006, Biochemical and biophysical research communications.

[8]  R. Wilton,et al.  Expression and purification of recombinant human receptor for advanced glycation endproducts in Escherichia coli. , 2006, Protein expression and purification.

[9]  Ann Marie Schmidt,et al.  Protein Glycation: A Firm Link to Endothelial Cell Dysfunction , 2004, Circulation research.

[10]  V. D’Agati,et al.  Blockade of receptor for advanced glycation endproducts: a new target for therapeutic intervention in diabetic complications and inflammatory disorders. , 2003, Archives of biochemistry and biophysics.

[11]  M. Brownlee.  Biochemistry and molecular cell biology of diabetic complications , 2001, Nature.

[12]  A. Schmidt,et al.  The biology of the receptor for advanced glycation end products and its ligands. , 2000, Biochimica et biophysica acta.

[13]  T. Kislinger,et al.  N ε-(Carboxymethyl)Lysine Adducts of Proteins Are Ligands for Receptor for Advanced Glycation End Products That Activate Cell Signaling Pathways and Modulate Gene Expression* , 1999, The Journal of Biological Chemistry.

[14]  R. Ziegler,et al.  AGEs and their interaction with AGE-receptors in vascular disease and diabetes mellitus. I. The AGE concept. , 1998, Cardiovascular research.

[15]  E. Schleicher,et al.  Increased accumulation of the glycoxidation product N(epsilon)-(carboxymethyl)lysine in human tissues in diabetes and aging. , 1997, The Journal of clinical investigation.

[16]  A. Schmidt,et al.  Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy of diabetes. , 1995, The Journal of clinical investigation.

[17]  K. O. Elliston,et al.  Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. , 1992, The Journal of biological chemistry.

[18]  T. Hughes,et al.  Advanced glycation end product ligands for the receptor for advanced glycation end products: biochemical characterization and formation kinetics. , 2004, Analytical biochemistry.